Anterior Cruciate Ligament Reconstruction Clinical Trial
Official title:
Implementation of the Knee Care @Home Programme for Patients Recovering Anterior Cruciate Ligament Reconstruction: Protocol for a Randomised Feasibility Trial
The main goal of this trial is to determine the feasibility of a randomized controlled trial for the Knee Care at Home Programme, rather than the effectiveness, for patients recovering from anterior cruciate ligament reconstruction. Specifically, the trial aims to: (1) assess the feasibility of studying the effectiveness of the Knee Care at Home programme, including patient engagement and satisfaction; and (2) conduct a qualitative assessment to identify barriers and facilitators in the implementation and delivery of the programme.
| Status | Not yet recruiting |
| Enrollment | 56 |
| Est. completion date | February 28, 2024 |
| Est. primary completion date | January 30, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 55 Years |
| Eligibility | Inclusion Criteria - Undergone primary ACLR regardless of surgical method and choice of autograft. - Have a healthy contralateral (opposite) knee. - The time between ACL injury and ACLR should not exceed 12 months. Exclusion Criteria - Declined to participate. - Concomitant osteochondral injuries. - Undergone multiple reconstructions of the lateral collateral ligament or posterior cruciate ligament. - Significant lower limb injuries within the 12 months before the ACL injury. - Medical conditions that may affect recovery. - Using medication for mental disorders. - Severe impairments in communication or balance. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Évora | Comprehensive Health Research Centre, Fundação para a Ciência e a Tecnologia, Hospital da Misericórdia de Évora |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Enrolment: Screening | Quantitative data: The number of patients with anterior cruciate ligament injury who were approached and scheduled for anterior cruciate ligament reconstruction.
Qualitative data: Open-ended questions posed to the orthopaedic surgeon regarding any ambiguities surrounding the screening procedure. |
Preoperative consultation | |
| Primary | Enrolment: Informed Consent | Quantitative data: The number of patients who have signed the informed consent. Qualitative data: Open-ended questions posed to patients regarding their reasons for not signing the consent form. | Preoperative consultation | |
| Primary | Enrolment: Eligibility | Quantitative data: (1) The number of patients assessed for eligibility; (2) The number of patients meeting the inclusion criteria; and (3) The number of patients included.
Qualitative data: (1) Open-ended questions to patients about the reasons for not participating; and (2) Open-ended question to orthopaedic surgeons about the reasons for patient ineligibility and enrollment ambiguities. |
First consultation after surgery (second week) | |
| Primary | Enrolment: Allocation | Quantitative data: (1) The number of patients who agreed to be randomly assigned; and (2) The number of patients who dropped out after randomisation.
Qualitative data: (1) Open-ended questions to patients about any problems they experienced with randomisation; and (2) Open-ended questions to orthopaedic surgeons about their reluctance to randomise patients. |
First consultation after surgery (second week) | |
| Primary | Data Collection: Response rates | Quantitative data includes the total number of outcome evaluation tools, the minutes spent using evaluation tools, and the number of unusable outcome measures. | Up to 36 weeks postoperative | |
| Primary | Data Collection: Missing data | Quantitative data includes the number of missing items. | Up to 36 weeks postoperative | |
| Primary | Data Collection: Implementation and Technical issues | Quantitative data: (1) Assessment of the costs and time allocated to resolving technical issues; and (2) Determination of the quantity of exercise and health coaches required to oversee patient recovery.
Qualitative data: (1) Open-ended questions to patients regarding any technical issues encountered during remote sessions; and (2) Open-ended questions to exercise and health coaches regarding the adequacy of resources for remote sessions. |
During each remote session, there will be a total of 22 weeks with 42 sessions between the 2nd and 24th postoperative week. | |
| Primary | Intervention Fidelity: Adherence to the trial | Patients will be assessed in three areas: [1] withdrawal rate, including the number of patients who completed at least one remote session and then decided to withdraw, as well as the time point of withdrawal decision (quantitative data), and open-ended questions to those who withdraw to explain their reasons (qualitative data); [2] completion rate, which measures the number of patients that attend all remote sessions and consultations (quantitative data); and [3] follow-up rate, which measures the number of patients who remained in the study throughout the intervention period as a proportion of the total number of participants recruited at baseline (quantitative data). | During each orthopaedic consultation, there will be a total of 7 consultations on the 2nd, 4th, 8th, 12th, 16th, 20th, and 24th postoperative weeks, spanning a total of 22 weeks. | |
| Primary | Intervention Fidelity: Adherence rate at Remote sessions | Areas: (1) General; (2) Consultations; (3) Compliance; and (4) Dosage.
Open-ended questions will be asked to participants and coaches about reasons for absence from remote sessions (qualitative data). Data will be collected on completed evaluation consultations and duration (quantitative data). Open-ended questions will be asked to patients, surgeons, and assessors about reasons for non-compliance with evaluation consultations (qualitative data). Data will be collected on attendance, cancellations, lateness, logins, and completed remote sessions (quantitative data). Patient log sheets will be evaluated for qualitative data. Data will be collected on completed remote sessions, session parameters, exercises, and costs (quantitative data). |
During each remote session, there will be a total of 22 weeks with 42 sessions between the 2nd and 24th postoperative week. | |
| Primary | Intervention Fidelity: Adherence rate at Conventional Clinic-based Rehabilitation | Quantitative data: (1) Determine the number of patients participating in conventional clinic-based rehabilitation; (2) Track the number of sessions per week and their duration; and (3) Calculate the indirect costs associated with conducting the sessions.
Qualitative Data: Open-ended questions posed to patients to gather information about the reasons for their absence from conventional clinic-based rehabilitation. |
During each orthopaedic consultation, there will be a total of 7 consultations on the 2nd, 4th, 8th, 12th, 16th, 20th, and 24th postoperative weeks, spanning a total of 22 weeks. | |
| Primary | Intervention Fidelity: Quality of delivery | Quantitative data: Questions about the exercise and health coach's capacity to deliver the remote sessions.
Qualitative data: Application of a questionnaire on an ordinal scale to patients about their self-rated level of agreement to statements about the exercise program using an 11-point Numeric Rating Scale (0 = strongly disagree and 10 = strongly agree). |
During each orthopaedic consultation, there will be a total of 7 consultations on the 2nd, 4th, 8th, 12th, 16th, 20th, and 24th postoperative weeks, spanning a total of 22 weeks. | |
| Primary | Intervention Fidelity: Participant Responsiveness | Quantitative data: (1) The number of exercises the patient was able to complete; and (2) The level of interest of patients in remote sessions based on previous criteria.
Qualitative data: Application of a questionnaire on an ordinal scale to exercise and health coaches about their perception of the participant's effort during the remote sessions (SIRAS Scale). |
During each remote session, there will be a total of 22 weeks with 42 sessions between the 2nd and 24th postoperative week. | |
| Primary | Intervention Fidelity: Safety (adverse events) | Quantitative data: (1) Assessing the frequency of signs and symptoms during remote sessions and between consultations; (2) Tracking the number of outcome measures showing no improvement or positive evolution; and (3) Recording the instances of exercise performance with excessive workload. | During each remote session, there will be a total of 22 weeks with 42 sessions between the 2nd and 24th postoperative week. | |
| Primary | Acceptability: Satisfaction | Qualitative data: Patients will be asked to respond to some open-ended questions about their experience in remote sessions. These questions will be about: (1) attendance; (2) positive and negative consequences the intervention; and (3) other parameters about the intervention satisfaction it self. There will be a predetermined questionnaire on a Likert Scale, from 0=very dissatisfied, to 4=very satisfied regarding general satisfaction. | During each orthopaedic consultation, there will be a total of 7 consultations on the 2nd, 4th, 8th, 12th, 16th, 20th, and 24th postoperative weeks, spanning a total of 22 weeks. | |
| Primary | Acceptability: Motivation | Qualitative data: Participants are asked an open-ended question about their motivation to participate in the intervention using remote sessions. | During each orthopaedic consultation, there will be a total of 7 consultations on the 2nd, 4th, 8th, 12th, 16th, 20th, and 24th postoperative weeks, spanning a total of 22 weeks. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06280456 -
Tranexamic Acid Injection With Different Drainage Clamping Time After Anterior Cruciate Ligament Reconstruction
|
N/A | |
| Active, not recruiting |
NCT02772770 -
Pediatric ACL: Understanding Treatment Options
|
||
| Terminated |
NCT00300300 -
Anterior Cruciate Ligament (ACL) Reconstruction Using Different Grafts and Surgical Techniques
|
Phase 4 | |
| Completed |
NCT00775892 -
SeriACLâ„¢ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair
|
Phase 1/Phase 2 | |
| Completed |
NCT04504344 -
Non-invasive Brain Stimulation to Improve Quadriceps Muscle Function After Anterior Cruciate Ligament Reconstruction
|
Phase 1 | |
| Recruiting |
NCT06327555 -
Study on the Effect of Telerehabilitation Using Wearable Devices After ACL Reconstruction
|
N/A | |
| Recruiting |
NCT05968729 -
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
|
N/A | |
| Not yet recruiting |
NCT05972876 -
Graft Maturity After Blood Flow Restriction Training in ACL Reconstruction
|
N/A | |
| Withdrawn |
NCT03688477 -
Iovera° to Treat Pain Associated With ACL Reconstruction and Rehabilitation
|
N/A | |
| Completed |
NCT02945553 -
Prevention of Skeletal Muscle Adaptations to Traumatic Knee Injury and Surgery
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01279759 -
Follow up of Patients Operated With Anterior Cruciate Ligament Reconstruction
|
N/A | |
| Completed |
NCT00245271 -
Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction
|
Phase 3 | |
| Recruiting |
NCT06131047 -
High Intensity Resistance Training With and Without Blood Flow Restriction in ACL Reconstruction
|
N/A | |
| Recruiting |
NCT06206200 -
The Effect of Cognitive Dual-task Rehabilitation on Arthrogenic Muscle Responses After ACL Reconstruction
|
N/A | |
| Recruiting |
NCT06430775 -
Exploring Prolonged AMR in ACL Reconstructed Patients
|
||
| Not yet recruiting |
NCT06318039 -
Operation ACL: Rehabilitation After Anterior Cruciate Ligament Reconstruction
|
N/A | |
| Recruiting |
NCT03336060 -
Neurophysiologic Correlates of Movement Planning During Complex Jump Landing Tasks and the Role of Cognitive Function
|
N/A | |
| Completed |
NCT03304561 -
The Effect of Contralateral Limb Training on Functional Outcomes in Patients With ACL Reconstruction
|
N/A | |
| Not yet recruiting |
NCT05619393 -
Comparison of Kinematic Movements Between ACL Deficiency With ACL Reconstruction and Healthy People
|
N/A | |
| Completed |
NCT02604550 -
Anterior Cruciate Ligament Pain Study
|
Phase 4 |